Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)

Rheumatology (United Kingdom)

Volumn 52, Issue 10, 2013, Pages 1795-1801

  Misra, Ramnath ^a   Danda, Debashish ^b   Rajappa, Sivakumar M ^c   Ghosh, Alakendu ^d   Gupta, Rajiva ^e   Mahendranath, Kurugodu M ^f   Jeyaseelan, Lakshmanan ^b   Lawrence, Able ^a   Bacon, Paul A ^g  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c Cerebrovascular and Vasculitis Research Foundation   (India)

^d Post Graduate Medical Education and Research Institute   (India)

^e MEDANTA THE MEDICITY   (India)

^f Samarpan Health Centre   (India)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Activity index; Acute phase response; India; IRAVAS; Large vessel disease; Longitudinal studies; Takayasu arteritis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN;

AORTA ARCH SYNDROME; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; CONVERGENT VALIDITY; DISEASE ACTIVITY; DISEASE EXTENT INDEX; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; INDIAN TAKAYASU CLINICAL ACTIVITY SCORE; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; PATIENT MONITORING; PHYSICIAN; PHYSICIAN GLOBAL ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VISUAL ANALOG SCALE;

EID: 84887369717     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket128     Document Type: Article

References (33)

1. Kerr GS, Hallahan CW, Giordano J et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
2. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in system necrotizing vasculitis. Q J Med 1994;87:671-8.
3. Exley AR, Bacon PA, Luqmani RA et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371-80.
4. de Groot K, Gross WL, Herlyn K et al. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001;55:31-8.
5. Bacon PA, Luqmani R. Assessment of disease, activity and damage. In: Ball E, Bridges SL, eds. Vasculitis. Oxford: Oxford University Press, 2002:246-54.
6. Flossmann O, Bacon P, de Groot K et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-92.
7. Hellmich B, Flossmann O, Gross WL et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605-17.
8. Mukhtyar C, Lee R, Brown D et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009;68:1827-32.
9. Gayraud M, Guillevin L, le Toumelin TP et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.
10. Exley AR, Carruthers DM, Luqmani RA et al. Damage occurs early in systemic vasculitis and is an index of outcome. Q J Med 1997;90:391-9.
11. Direskeneli H, Aydin SZ, Kermani TA et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011;38:1471-9.
12. Misra R, Sivakumar MR, Bambery P et al. Validation of BVAS and VDI: Indian Rheumatology Association core group experience. J Ind Rheum Assoc 2004;12:78-81.
13. Sivakumar M, Agarwal A, Krishnamurthy V et al. Disease Extent Index in Takayasu arteritis. Kidney Blood Press Res 2005;28:191-2.
14. Aydin SZ, Yilmaz N, Akar S et al. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu. Rheumatology 2010;49:1889-93.
15. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol 2011;29(1 Suppl 64):S86-91.
16. Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol 2010;6:406-15.
17. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998;66(Suppl 1):S191-4.
18. Numano F. Takayasu's arteritis: clinical aspects. In: Hoffman GS, Weyand CM, eds. Inflammatory diseases of blood vessels. New York: Marcel Dekker, 2002:455-66.
19. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an american cohort of Takayasu arteritis patients. Arthritis Rheum 2008;56:1000-9.
20. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 2008;47:403-8.
21. Kobayashi Y, Ishii K, Oda K et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005;46:917-22.
22. Meller J, Strutz F, Siefker U et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730-6.
23. Park MC, Lee SW, Park YB et al. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology 2006;45:545-8.
24. Lapraik C, Watts R, Bacon P et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology 2007;46:1615-6.
25. Aluquin VP, Albano SA, Chan F et al. Magnetic resonance imaging in the diagnosis and follow up of Takayasu's arteritis in children. Ann Rheum Dis 2002;61:526-9.
26. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004;16:31-7.
27. de Leeuw K, Bijl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 2004;22(6 Suppl 36):S21-6.
28. Yee CS, Farewell V, Isenberg DA et al. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 2006;54:3300-5.
29. Meller J, Grabbe E, Becker W et al. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003;13:400-5.
30. Takahashi M, Momose T, Kameyama M et al. Abnormal accumulation of [18F]fluorodeoxyglucose in the aortic wall related to inflammatory changes: three case reports. Ann Nucl Med 2006;20:361-4.
31. Derdelinckx I, Maes A, Bogaert J et al. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol 2000;55:193-5.
32. Mekinian A, Neel A, Sibilia J et al. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study. Rheumatology 2012;51:882-6.
33. Salvarani C, Magnani L, Catanoso M et al. Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology 2012;51:151-6.